Kim Yuhree, Ejaz Aslam, Xu Li, Gani Faiz, Canner Joseph K, Schneider Eric B, Pawlik Timothy M
Department of Surgery, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Blalock 688, Baltimore, MD 21287, USA.
Department of Surgery, University of Illinois Hospital and Health Sciences System, Chicago, IL, USA.
Am J Surg. 2016 Aug;212(2):305-314.e2. doi: 10.1016/j.amjsurg.2016.01.028. Epub 2016 Apr 12.
Most studies on readmission only report data on first readmission within 30 days. These data may underestimate the true impact of readmission, as recurrent readmissions are common among patients undergoing major surgery. We therefore sought to define characteristics and readmission patterns of patients recurrently readmitted after major surgery.
A total of 81,769 patients discharged after 10 major surgical procedures (coronary artery bypass graft, abdominal aortic aneurysm, carotid endarterectomy, aortic valve replacement, esophagectomy, gastrectomy, pancreatectomy, pulmonary resection, hepatectomy, and colorectal resection) between 2010 and 2012 were identified from a large employer-provided health plan. Maximum number of unplanned readmissions experienced within 365 days of discharge was measured.
Median patient age was 55 years, and a slight majority (55.4%) was male. Comorbidities were common as 36.9% had a Charlson comorbidity index (CCI) of ≥2. Median length of stay was 5 (interquartile range, 3 and 8) days. Among 24,344 (29.8%) patients who experienced readmission, 64.0% experienced 1 readmission, whereas 36.0% experienced recurrent readmissions within 365 day of a prior discharge. Compared with patients experiencing 1 readmission, patients with ≥2 readmissions were more likely to be female (47.3% vs 44.2%) and have more comorbidities (Charlson comorbidity index ≥2, 49.5% vs 42.5%; both P < .001). Complications during the index hospitalization were more common among patients experiencing recurrent readmissions (35.5% vs 30.7%, P < .001). Although median length of stay during index hospitalization was longer among patients with recurrent readmissions (6 vs 7 days), median time to first readmission was shorter (97 vs 40 days, both P < .001). Among study cohort, 4.5% experienced 3 or more readmissions; these patients accounted for 14.8% of all admissions and 13.7% of hospital charges for the study cohort during the entire follow-up period.
Among patients who underwent major surgery, 3 in 10 patients experienced readmission of which 1 in 10 patients experienced recurrent readmission within 1 year after surgery. Overall 4.5% of patients with ≥3 readmissions accounted for 14.8% of total admission during the study period. Assessment of only first rehospitalization may not fully capture the long-term outcomes after major surgery.
大多数关于再入院的研究仅报告30天内首次再入院的数据。这些数据可能低估了再入院的真实影响,因为在接受大手术的患者中反复再入院很常见。因此,我们试图确定大手术后反复再入院患者的特征和再入院模式。
从一个大型雇主提供的健康计划中识别出2010年至2012年间接受10种大手术(冠状动脉搭桥术、腹主动脉瘤手术、颈动脉内膜切除术、主动脉瓣置换术、食管切除术、胃切除术、胰腺切除术、肺切除术、肝切除术和结肠直肠切除术)后出院的81769名患者。测量出院后365天内经历的计划外再入院的最大次数。
患者年龄中位数为55岁,男性略占多数(55.4%)。合并症很常见,36.9%的患者Charlson合并症指数(CCI)≥2。住院时间中位数为5天(四分位间距为3至8天)。在24344名(29.8%)经历再入院的患者中,64.0%经历了1次再入院,而36.0%在先前出院的365天内经历了反复再入院。与经历1次再入院的患者相比,再入院≥2次的患者更可能为女性(47.3%对44.2%)且合并症更多(Charlson合并症指数≥2,49.5%对42.5%;P均<0.001)。在反复再入院的患者中,首次住院期间的并发症更常见(35.5%对30.7%,P<0.001)。尽管反复再入院患者首次住院期间的住院时间中位数较长(6天对7天),但首次再入院的中位时间较短(97天对40天,P均<0.001)。在研究队列中,4.5%的患者经历了3次或更多次再入院;在整个随访期间,这些患者占研究队列所有入院人数的14.8%和医院费用的13.7%。
在接受大手术的患者中,十分之三的患者经历了再入院,其中十分之一的患者在术后1年内经历了反复再入院。总体而言,再入院≥3次的患者中有4.5%在研究期间占总入院人数的14.8%。仅评估首次再次住院可能无法完全反映大手术后的长期结局。